|
| Press Releases |
|
 |
|
| Monday, May 9, 2022 |
|
|
骏高公布二零二二年首季业绩 业务稳步发展 令收益增长 |
于香港创立并以本地为基地及亚洲为策略重心的货运代理及物流一站式服务供应商骏高控股有限公司（「骏高」或「集团」；股份代号：8035），今天公布其2022年3月31日止三个月（「回顾期」）的未经审核2022年首季业绩。
more info >> |
|
|
駿高公布二零二二年首季業績 業務穩步發展 令收益增長 |
| 於香港創立並以本地為基地及亞洲為策略重心的貨運代理及物流一站式服務供應商駿高控股有限公司（「駿高」或「集團」；股份代號：8035），今天公布其2022年3月31日止三個月（「回顧期」）的未經審核2022年首季業績。 more info >> |
|
|
Janco Announces 2022 First Quarter Results, Business Steadily Develops as Revenue Grows |
| Janco Holdings Limited ("Janco" or the "Group"; Stock Code: 8035), a comprehensive freight forwarding and logistics services provider founded and based in Hong Kong with a strategic focus on Asia, has today announced its 2022 unaudited results for the three months ended 31 March 2022 ("Period under Review"). more info >> |
|
| Monday, April 25, 2022 |
|
|
骏高经审计之二零二一年全年业绩：股东应占溢利增加54.5%至17.3百万港元 |
| 于香港创立并以本地为基地及亚洲为策略重心的货运代理及物流一站式服务供货商骏高控股有限公司（「骏高」或「集团」；股份代号：8035）公布截至2021年12月31日止年度经审计之全年业绩（「回顾年内」）。 more info >> |
|
|
駿高經審計之二零二一年全年業績：股東應佔溢利增加54.5%至17.3百萬港元 |
| 於香港創立並以本地為基地及亞洲為策略重心的貨運代理及物流一站式服務供應商駿高控股有限公司（「駿高」或「集團」；股份代號：8035）公布截至2021年12月31日止年度經審計之全年業績（「回顧年內」）。 more info >> |
|
|
Janco 2021 Audited Annual Results: Profit Attributable to Shareholders Surges by 54.5% to HK$17.3 million |
| Janco Holdings Limited ("Janco" or the "Group"; Stock Code: 8035), a one-stop freight forwarding and logistics service provider founded and based in Hong Kong with a strategic focus on Asia, announced its 2021 audited annual results for the year ended 31 December 2021 ("Year under Review"). more info >> |
|
| Sunday, March 27, 2022 |
|
|
骏高控股公布二零二一年全年业绩 |
| 骏高控股有限公司（「骏高」或「集团」；股份代号：8035） 是在香港创立并以本地为基地及亚洲为策略重心的货运代理及物流一站式服务供货商，公布截至2021年12月31日止年度之二零二一年未经审核*之初步全年业绩。 more info >> |
|
|
駿高控股公布二零二一年全年業績 |
| 駿高控股有限公司（「駿高」或「集團」；股份代號：8035） 是在香港創立並以本地為基地及亞洲為策略重心的貨運代理及物流一站式服務供應商，公布截至2021年12月31日止年度之二零二一年未經審核*之初步全年業績。 more info >> |
|
|
Janco Holdings Announces 2021 Annual Results |
| Janco Holdings Limited ("Janco" or the "Group"; Stock Code: 8035), a well-established freight forwarding and logistics one-stop service provider founded and based in Hong Kong with a strategic focus on Asia, announced its 2021 unaudited* preliminary annual results for the year ended 31 December 2021. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Kangji Medical Receives Privatisation Proposal from a Consortium Led by Kangji Medical's Chairman, Zhong Ming, TPG and QIA to Advance Long-Term Strategic Vision
Aug 13, 2025 23:21 HKT/SGT
|
|
|
GEON Performance Solutions Achieves Great Place to Work Recognition Globally Second Year in a Row
Aug 13, 2025 23:18 HKT/SGT
|
|
|
AI Inference vs. AI Training: What Are the Differences?
Aug 13, 2025 23:03 HKT/SGT
|
|
|
Shoucheng Joins World Humanoid Robot Games - 88 Spectators Invited
Aug 13, 2025 22:33 HKT/SGT
|
|
|
MMG Announces 2025 Interim Results, Profit, Earnings and Cash up on Strong Copper Growth
Aug 13, 2025 22:31 HKT/SGT
|
|
|
Formerra Becomes North American Distributor for Syensqo PVDF
Aug 13, 2025 21:32 HKT/SGT
|
|
|
China Lilang Announces 2025 Interim Results
Aug 13, 2025 21:30 HKT/SGT
|
|
|
NMPA已受理亿胜生物关于EB12-20145P（HLX04-O）用于治疗湿性年龄相关性黄斑变性的生物制品许可申请
Aug 13, 2025 21:25 HKT/SGT
|
|
|
NMPA Accepted Essex's Biologics License Application for EB12-20145P (HLX04-O) for the Treatment of Wet Age-Related Macular Degeneration
Aug 13, 2025 21:24: JST
|
|
|
NMPA Accepted Essex's Biologics License Application for EB12-20145P (HLX04-O) for the Treatment of Wet Age-Related Macular Degeneration
Aug 13, 2025 20:24 HKT/SGT
|
|
|
NMPA已受理億勝生物關於EB12-20145P（HLX04-O）用於治療濕性年齡相關性黃斑變性的生物製品許可申請
Aug 13, 2025 20:24 HKT/SGT
|
|
|
潼關黃金獲納入MSCI全球小型股指數 資本市場影響力進一步提升
Aug 13, 2025 19:19 HKT/SGT
|
|
|
AsiaMedic Reports 26% Revenue Growth to S$16.6 million in 1H2025, Led by Strong Diagnostic Imaging Performance
Aug 13, 2025 14:00 HKT/SGT
|
|
|
74th China (Linyi) International Hardware Expo to Open September 5-7, 2025 in Shandong
Aug 13, 2025 13:00: JST
|
|
|
74th China (Linyi) International Hardware Expo to Open September 5-7, 2025 in Shandong
Aug 13, 2025 12:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
